YJ Biotechnology has published a new study highlighting the advantages of Isolator-based point-of-care (POC) manufacturing for cell therapies and extracellular vesicles (EVs). As the field of regenerative medicine rapidly evolves, POC production models provide a practical solution for delivering fresh, high-quality therapeutic products with minimized contamination risk and shortened vein-to-vein time.
Once damaged, articular cartilage is difficult to repair due to its lack of blood supply. Over time, this may lead to joint degeneration and impaired quality of life. To address this challenge, YJ Biotechnology has developed a novel approach that combines exosomes with intelligent biomaterial scaffolds (cryogels)—offering a promising breakthrough for cartilage regeneration.
Stroke is one of the leading causes of adult disability worldwide, and brain damage often leads to long-term neurological impairments. Our research shows that intravenous injection of WJ-MSC-derived exosomes significantly reduces the infarct volume in stroke rats while improving their motor function and limb strength.
Since its establishment in 2020, YJ Biotechnology has been revolutionizing the field of regenerative medicine with its cost-efficient, internationally-certified, and decentralized one-stop cell manufacturing platform—supporting both industrial-scale and academic applications of stem cells and exosomes.
Looking to build high-quality exosome products? This article breaks down 7 essential manufacturing equipment — from cell expansion to aseptic lyophilization — and introduces how the YJ-Isolator enables compliant, scalable, and closed-system production for clinical and commercial use.
Want to know how exosomes are made? Discover the 4 key technologies behind exosome manufacturing — from high-efficiency cell expansion and AIoT process control to aseptic lyophilization and GMP compliance — for stable, high-quality, and legally approved products.
YJ Biotechnology has spent three years developing isolator for cell pharmaceuticals, providing with immune cells, stem cells and other cell production processes to further improve the safety of sterile cell preparations.
YJ QC Laboratory has obtained the Taiwan Accreditation Foundation (TAF) ISO/IEC 17025:2017 certified laboratory. (Certification number: 4146)
We will continue to provide testing services with higher quality and confidence in the future.
Dr. Nguyen Huu Tung with the representative of YJ Biotechnology Corporation
signed a memorandum of understanding on cooperation on June 6th, 2023
By clicking “Accept All”, you agree to the storing of cookies on your device to support certain functionality, analyze trends, administer our websites, track user movements around the websites and to gather demographic information about our user base as a whole.
Privacy preferences
By clicking “Accept All”, you agree to the storing of cookies on your device to support certain functionality, analyze trends, administer our websites, track user movements around the websites and to gather demographic information about our user base as a whole.
Manage preferences
Necessary cookie
The website cannot function without these cookies and you cannot switch them off on your system. These cookies are typically set only in response to an action you perform (i.e. a service request), such as setting privacy preferences, logging in, or filling in a form. You can set your browser to block or prompt you for these cookies, but this may prevent some site features from working.
